<iframe src="https://www.googletagmanager.com/ns.html?id=GTM-WR9VRVQ" height="0" width="0" style="display:none;visibility:hidden">

press center

ProPharma is at the forefront of the life sciences industry and continues to innovate and elevate its position as the world’s largest RCO. Stay up to date on ProPharma’s latest news and most recent announcements.

Company News

June 2, 2021

New Manufacturing and Import License Expands Batch Certification Services

ProPharma Group announced that its wholly-owned subsidiary ProPharma Group The Netherlands B.V., has obtained an authorization for a manufacturing and import (MIA) license. Following successful...

Company News

May 27, 2021

ProPharma Group and The Planet Group Announce Agreement to Merge

ProPharma Group and The Planet Group have reached a definitive agreement to merge the two companies. ProPharma Group, a portfolio company of Odyssey Investment Partners, is the leading global...

Company News

March 2, 2021

ProPharma Group Announces the Acquisition of Diamond Pharma Services

ProPharma Group, a portfolio company of Odyssey Investment Partners, announces the acquisition of Diamond Pharma Services. Diamond Pharma Services provides regulatory affairs, pharmacovigilance, and...

Company News

December 15, 2020

Mydecine Innovations Group Engages ProPharma Group to Proceed with FDA Filings and Approval for Novel Research and Multiple Phase Clinical Trials

DENVER, Dec. 15, 2020 (GLOBE NEWSWIRE) -- Mydecine Innovations Group (CSE: MYCO) (OTC: MYCOF) (“Mydecine” or the “Company”), an emerging biopharma and life sciences company committed to the research,...

Company News

September 22, 2020

Odyssey Investment Partners To Acquire ProPharma Group

Odyssey Investment Partners To Acquire ProPharma Group: Odyssey Investment Partners ("Odyssey") announced today that it has entered into an agreement to acquire ProPharma Group (or the "Company")...

Company News

September 22, 2020

Linden Agrees to Sell ProPharma Group to Odyssey Investment Partners

Linden Capital Partners (“Linden”), a Chicago-based private equity firm focused exclusively on the healthcare sector, announced an agreement to sell ProPharma Group (the “Company”) to Odyssey...

Press Releases News featured-image

January 09, 2023

ProPharma Group launches revolutionary new operating model

$50m investment and rebrand unveiled at J.P. Morgan Healthcare Conference as part of new global growth strategy. RALEIGH, NC, January 9, 2023: ProPharma Group – the end-to-end, global provider of...

Read More
Company News featured-image

January 09, 2023

Drug and Device Development Outsourcing 2.0 - Soaring Beyond the CRO

ProPharma Group - the end-to-end, global provider of regulatory, clinical and compliance services for the pharmaceutical, biotechnology and medical device industries launched the Research Consulting...

Read More
Company News Acquisitions featured-image

January 25, 2023

ProPharma Announces Acquisition of Digital Lab Consulting

PROPHARMA ANNOUNCES ACQUISITION OF UK-BASED DIGITAL LAB CONSULTING  TO EXPAND R&D CAPABILITIES AND ACCELERATE PRODUCT DEVELOPMENT RALEIGH, NC, January 25, 2023: ProPharma Group (ProPharma) the...

Read More
Press Releases featured-image

April 03, 2023

ProPharma Announces New Global Headquarters in Raleigh, NC as Hub for Innovation and Talent

RALEIGH, NC, April 3, 2023: ProPharma Group (ProPharma), the leading global provider of regulatory, clinical and compliance services for the life sciences industry and a portfolio company of Odyssey...

Read More
Company News featured-image

March 02, 2021

ProPharma Group Announces the Acquisition of Diamond Pharma Services

ProPharma Group, a portfolio company of Odyssey Investment Partners, announces the acquisition of Diamond Pharma Services. Diamond Pharma Services provides regulatory affairs, pharmacovigilance, and...

Read More
Press Releases featured-image

March 01, 2023

ProPharma Announces the Appointment of Karl Deonanan as New Chief Financial Officer

Raleigh, NC, March 1, 2023: ProPharma Group (ProPharma), the leading global provider of regulatory, clinical and quality services for the life sciences industry and a portfolio company of Odyssey...

Read More
Prev 2 3 4 5 6 Next

Inspiring the Future of Drug Development

We’ve developed a process that suits the today’s needs and a better experience for clients. Our industry is constantly changing. Let us help you accelerate your innovation.